Departments of Tissue Pathology and Diagnostic Oncology, Medical Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney.
Central Clinical School, University of Sydney, Sydney; Douglass Hanly Moir Pathology, North Ryde, Sydney; Department of Radiation Oncology, Royal North Shore Hospital, St Leonards, Sydney, New South Wales; Focus Pathology, South Yarra, Melbourne, Victoria; Division of Surgical Pathology, SA Pathology, Adelaide; Adelaide Pathology Partners, Mile End, Adelaide; Urology, Calvary Hospital, North Adelaide, South Australia; Aquesta Pathology, Brisbane, Queensland, Australia; Department of Oncology - Pathology, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden; Department of Pathology and Molecular Medicine, McMaster University, ON, Canada; Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand.
Prostate cancer is the most common visceral cancer and the second most common cause of cancer death in males. The number of radical prostatectomies performed each year is increasing and accurate data from the histopathological examination of these specimens aid clinicians in stratifying patients for surveillance and adjuvant therapies. This review focuses on the histopathological prognostic factors which should be routinely recorded in pathology reports and complements the Royal College of Pathologists of Australasia Structured Reporting Protocol for Prostate Cancer (Radical Prostatectomy). Such structured pathology reports have been shown to significantly enhance the completeness and quality of data provided to clinicians. The review also discusses the International Society for Urological Pathology Consensus Conference recommendations which were published recently.
Written by:
Kench JG, Clouston DR, Delprado W, Eade T, Ellis D, Horvath LG, Samaratunga H, Stahl J, Stapleton AM, Egevad L, Srigley JR, Delahunt B. Are you the author?
Reference: Pathology. 2011 Jun 29. Epub ahead of print.
PubMed Abstract
PMID: 21716159
UroToday.com Prostate Cancer Section
